Skip to content

Author

F. D'Amico

We have 2 of 234 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Advanced Therapies for the Management of Immune Checkpoint Inhibitor-Induced Colitis

Simple Summary Immune checkpoint inhibitors help the body’s immune system attack tumors and have greatly improved survival for many cancer patients. However, by boosting the immune system, these drugs can also cause it to attack healthy tissue, and inflammation of the bowel is one of the most common and serious side ef...

C. S. Matichecchia, F. Fanizzi, A. Zilli et al. · 0 citations
Open access Sep 2026

Real-World Effectiveness and Safety of Upadacitinib in Patients With Crohn's Disease-A Multicentre Prospective Study From the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Upadacitinib was effective and well-tolerated in AT-experienced Crohn's disease, including patients with active EIMs, with induction benefit maintained through 6 months without novel safety signals.

B. Barberio, F. D'Amico, L. Laterza et al. · 2 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.